These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32438615)

  • 21. Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages.
    Jin SL; Lan L; Zoudilova M; Conti M
    J Immunol; 2005 Aug; 175(3):1523-31. PubMed ID: 16034090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain.
    Iona S; Cuomo M; Bushnik T; Naro F; Sette C; Hess M; Shelton ER; Conti M
    Mol Pharmacol; 1998 Jan; 53(1):23-32. PubMed ID: 9443929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling.
    Houslay MD; Baillie GS; Maurice DH
    Circ Res; 2007 Apr; 100(7):950-66. PubMed ID: 17431197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Phosphodiesterase 4B cAMP-Specific Gene in Subjects With Cryptorchidism and Down's Syndrome.
    Salemi M; Condorelli RA; La Vignera S; Castiglione R; Salluzzo MG; Bonaccorso CM; Vinci M; Bosco P; Romano C; Campagna C; Romano C; Calogero AE
    J Clin Lab Anal; 2016 May; 30(3):196-9. PubMed ID: 25546171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B.
    Johanns M; Lai YC; Hsu MF; Jacobs R; Vertommen D; Van Sande J; Dumont JE; Woods A; Carling D; Hue L; Viollet B; Foretz M; Rider MH
    Nat Commun; 2016 Mar; 7():10856. PubMed ID: 26952277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microglia in vitro and following CNS injury.
    Ghosh M; Garcia-Castillo D; Aguirre V; Golshani R; Atkins CM; Bramlett HM; Dietrich WD; Pearse DD
    Glia; 2012 Dec; 60(12):1839-59. PubMed ID: 22865690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diazepam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDE4A1 and PDE4B3 in the mouse.
    Cherry JA; Thompson BE; Pho V
    Biochim Biophys Acta; 2001 Mar; 1518(1-2):27-35. PubMed ID: 11267656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor.
    Keravis T; Monneaux F; Yougbaré I; Gazi L; Bourguignon JJ; Muller S; Lugnier C
    PLoS One; 2012; 7(1):e28899. PubMed ID: 22247763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family.
    McPhee I; Pooley L; Lobban M; Bolger G; Houslay MD
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):965-74. PubMed ID: 7575434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of phosphodiesterase-4 subtypes involved in surgery-induced neuroinflammation and cognitive dysfunction in mice.
    Wang W; Zhang XY; Feng ZG; Wang DX; Zhang H; Sui B; Zhang YY; Zhao WX; Fu Q; Xu ZP; Mi WD
    Brain Res Bull; 2017 Apr; 130():274-282. PubMed ID: 28235598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphodiesterase 4 and its inhibitors in inflammatory diseases.
    Jin SL; Ding SL; Lin SC
    Chang Gung Med J; 2012; 35(3):197-210. PubMed ID: 22735051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders.
    Bhat A; Ray B; Mahalakshmi AM; Tuladhar S; Nandakumar DN; Srinivasan M; Essa MM; Chidambaram SB; Guillemin GJ; Sakharkar MK
    Pharmacol Res; 2020 Oct; 160():105078. PubMed ID: 32673703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of phosphodiesterase-4 (PDE4) activity triggers luminal apoptosis and AKT dephosphorylation in a 3-D colonic-crypt model.
    Tsunoda T; Ota T; Fujimoto T; Doi K; Tanaka Y; Yoshida Y; Ogawa M; Matsuzaki H; Hamabashiri M; Tyson DR; Kuroki M; Miyamoto S; Shirasawa S
    Mol Cancer; 2012 Jul; 11():46. PubMed ID: 22830422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatiotemporal dynamics of beta-adrenergic cAMP signals and L-type Ca2+ channel regulation in adult rat ventricular myocytes: role of phosphodiesterases.
    Leroy J; Abi-Gerges A; Nikolaev VO; Richter W; Lechêne P; Mazet JL; Conti M; Fischmeister R; Vandecasteele G
    Circ Res; 2008 May; 102(9):1091-100. PubMed ID: 18369156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding PDE4's function in Alzheimer's disease; a target for novel therapeutic approaches.
    Tibbo AJ; Tejeda GS; Baillie GS
    Biochem Soc Trans; 2019 Oct; 47(5):1557-1565. PubMed ID: 31642904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy.
    Wang L; Burmeister BT; Johnson KR; Baillie GS; Karginov AV; Skidgel RA; O'Bryan JP; Carnegie GK
    Cell Signal; 2015 May; 27(5):908-22. PubMed ID: 25683917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PDE4 associates with different scaffolding proteins: modulating interactions as treatment for certain diseases.
    McCahill AC; Huston E; Li X; Houslay MD
    Handb Exp Pharmacol; 2008; (186):125-66. PubMed ID: 18491051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling.
    Millar JK; Pickard BS; Mackie S; James R; Christie S; Buchanan SR; Malloy MP; Chubb JE; Huston E; Baillie GS; Thomson PA; Hill EV; Brandon NJ; Rain JC; Camargo LM; Whiting PJ; Houslay MD; Blackwood DH; Muir WJ; Porteous DJ
    Science; 2005 Nov; 310(5751):1187-91. PubMed ID: 16293762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noradrenergic lesions differentially alter the expression of two subtypes of low Km cAMP-sensitive phosphodiesterase type 4 (PDE4A and PDE4B) in rat brain.
    Farooqui SM; Zhang K; Makhay M; Jackson K; Farooqui SQ; Cherry JA; O'Donnell JM
    Brain Res; 2000 Jun; 867(1-2):52-61. PubMed ID: 10837797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rolipram attenuates bile duct ligation-induced liver injury in rats: a potential pathogenic role of PDE4.
    Gobejishvili L; Barve S; Breitkopf-Heinlein K; Li Y; Zhang J; Avila DV; Dooley S; McClain CJ
    J Pharmacol Exp Ther; 2013 Oct; 347(1):80-90. PubMed ID: 23887098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.